Search Results

There are 4879 results for: content related to: Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours

  1. Structure and DNA binding characteristics of the three-Cys2His2 domain of mouse testis zinc finger protein

    Proteins: Structure, Function, and Bioinformatics

    Volume 78, Issue 10, 1 August 2010, Pages: 2202–2212, Chun-Chi Chou, Yuan-Chao Lou, Tang K. Tang and Chinpan Chen

    Article first published online : 31 MAR 2010, DOI: 10.1002/prot.22732

  2. You have free access to this content
    Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus–transgenic mice by peroxisome proliferator-activated receptor γ–independent regulation of nucleophosmin

    Hepatology

    Volume 52, Issue 2, August 2010, Pages: 493–505, Andrea Galli, Elisabetta Ceni, Tommaso Mello, Simone Polvani, Mirko Tarocchi, Francesca Buccoliero, Francesca Lisi, Laura Cioni, Barbara Ottanelli, Valeria Foresta, Guido Mastrobuoni, Gloriano Moneti, Giuseppe Pieraccini, Calogero Surrenti and Stefano Milani

    Article first published online : 15 MAR 2010, DOI: 10.1002/hep.23669

  3. The potentially inappropriate prescription of new drug: thiazolidinediones for patients with type II diabetes in Taiwan

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 1, January 2011, Pages: 20–29, Yu-Wen Wen, Yi-Wen Tsai, Weng-Foung Huang, Fei-Yuan Hsiao and Pei-Fen Chen

    Article first published online : 1 DEC 2010, DOI: 10.1002/pds.2010

  4. You have free access to this content
    Thiazolidinedione inhibits production of RANTES in a cytokine-treated human lung epithelial cell line

    FEBS Letters

    Volume 452, Issue 3, June 11, 1999, Pages: 301–304, Atsuko Momoi, Koji Murao, Hitomi Imachi, Yoshitaka Sayo, Hiroyuki Nakamura, Hitoshi Hosokawa, Makoto Sato, Jiro Fujita, Hiroki Okada, Toshihiko Ishida and Jiro Takahara

    Article first published online : 11 JUN 1999, DOI: 10.1016/S0014-5793(99)00678-X

  5. New drugs and the growth of health expenditure: evidence from diabetic patients in Taiwan

    Health Economics

    Volume 21, Issue 5, May 2012, Pages: 496–513, Ya-Ming Liu and Chee-Ruey Hsieh

    Article first published online : 10 MAR 2011, DOI: 10.1002/hec.1724

  6. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 507–514, Marloes T. Bazelier, Arlene M. Gallagher, Tjeerd-Pieter van Staa, Cyrus Cooper, Hubert G. M. Leufkens, Peter Vestergaard and Frank de Vries

    Article first published online : 6 MAR 2012, DOI: 10.1002/pds.3234

  7. Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 12, December 2014, Pages: 1247–1256, M. Gokhale, J. B. Buse, C. L. Gray, V. Pate, M. A. Marquis and T. Stürmer

    Article first published online : 10 SEP 2014, DOI: 10.1111/dom.12379

  8. Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 4, April 2008, Pages: 312–328, R. E. Buckingham and A. Hanna

    Article first published online : 16 JAN 2007, DOI: 10.1111/j.1463-1326.2006.00700.x

  9. Rotational co-culture of clonal β-cells with endothelial cells: effect of PPAR-γ agonism in vitro on insulin and VEGF secretion

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 7, July 2011, Pages: 662–668, M. B. Paget, H. E. Murray, C. J. Bailey, P. R. Flatt and R. Downing

    Article first published online : 24 MAY 2011, DOI: 10.1111/j.1463-1326.2011.01392.x

  10. Thiazolidinedione use in elderly patients with type 2 diabetes: with and without heart failure

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 4, April 2011, Pages: 344–350, Jong-Mi Seong, Nam-Kyong Choi, Sun-Young Jung, Yoosoo Chang, Ye-Jee Kim, Joongyub Lee and Byung-Joo Park

    Article first published online : 17 FEB 2011, DOI: 10.1002/pds.2112

  11. You have free access to this content
    Chronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism

    British Journal of Pharmacology

    Volume 128, Issue 6, November 1999, Pages: 1141–1148, C Fürnsinn, B Brunmair, M Meyer, S Neschen, R Furtmüller, M Roden, H F Kühnle, P Nowotny, B Schneider and W Waldhäusl

    Article first published online : 30 JAN 2009, DOI: 10.1038/sj.bjp.0702886

  12. Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 8, August 2010, Pages: 716–721, R. E. Aubert, V. Herrera, W. Chen, S. M. Haffner and M. Pendergrass

    Article first published online : 23 MAR 2010, DOI: 10.1111/j.1463-1326.2010.01225.x

  13. Effect of structural modifications on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats

    Journal of Applied Toxicology

    Volume 32, Issue 2, February 2012, Pages: 108–117, Niti N. Patel, Christine M. Crincoli, Douglas M. Frederick, Ruy Tchao and Peter J. Harvison

    Article first published online : 21 FEB 2011, DOI: 10.1002/jat.1639

  14. You have full text access to this Open Access content
    Role of peroxisome proliferator-activated receptor gamma agonist in improving hepatic steatosis: Possible molecular mechanism

    Journal of Diabetes Investigation

    Volume 3, Issue 2, April 2012, Pages: 93–95, Cheol-Young Park and Sung Woo Park

    Article first published online : 8 MAR 2012, DOI: 10.1111/j.2040-1124.2012.00204.x

  15. Synthesis and biological activities of some new thiazolidine derivatives containing pyrazole ring system

    Journal of Heterocyclic Chemistry

    Volume 49, Issue 2, March 2012, Pages: 303–309, Sho Nishida, Hiroshi Maruoka, Yuki Yoshimura, Takao Goto, Ryoko Tomita, Eiichi Masumoto, Fumi Okabe, Kenji Yamagata and Toshihiro Fujioka

    Article first published online : 22 NOV 2011, DOI: 10.1002/jhet.834

  16. Synthesis of New N-Substituted 5-Arylidene-2,4-thiazolidinediones as Anti-Inflammatory and Antimicrobial Agents

    Archiv der Pharmazie

    Volume 346, Issue 6, June 2013, Pages: 481–490, Cristina Nastasă, Brînduşa Tiperciuc, Alina Pârvu, Mihaela Duma, Ioana Ionuţ and Ovidiu Oniga

    Article first published online : 13 MAY 2013, DOI: 10.1002/ardp.201300021

  17. Relationship between cumulative dose of thiazolidinediones and clinical outcomes in type 2 diabetic patients with history of heart failure: a population-based cohort study in Taiwan

    Pharmacoepidemiology and Drug Safety

    Volume 19, Issue 8, August 2010, Pages: 786–791, Fei-Yuan Hsiao, Yi-Wen Tsai, Yu-Wen Wen, Pei-Fen Chen, Hao-Yu Chou, Chen-Huan Chen, Ken N. Kuo and Weng-Foung Huang

    Article first published online : 2 JUL 2010, DOI: 10.1002/pds.1999

  18. Thiazolidinediones and congestive heart failure in veterans with type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 3, March 2011, Pages: 276–280, A. Toprani and V. Fonseca

    Article first published online : 24 JAN 2011, DOI: 10.1111/j.1463-1326.2010.01348.x

    Corrected by:

    Corrigendum

    Vol. 14, Issue 4, 386, Article first published online: 5 MAR 2012

  19. You have full text access to this Open Access content
    Thiazolidinediones and bone fractures

    Journal of Diabetes Investigation

    Volume 2, Issue 5, October 2011, Pages: 354–355, Kohei Kaku and Mitsuru Hashiramoto

    Article first published online : 23 JUN 2011, DOI: 10.1111/j.2040-1124.2011.00142.x

  20. You have full text access to this OnlineOpen article
    The relationship between risk of bias criteria, research outcomes, and study sponsorship in a cohort of preclinical thiazolidinedione animal studies: a meta-analysis

    Evidence-based Preclinical Medicine

    Volume 1, Issue 1, December 2014, Pages: 11–20, M. Abdel-Sattar, D. Krauth, A. Anglemyer and L. Bero

    Article first published online : 20 JAN 2015, DOI: 10.1002/ebm2.5